JERUSALEM--(BUSINESS WIRE)--Feb. 25, 2013--
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio
webcast at the 2013 RBC Capital Markets Global Healthcare Conference.
Jon Congleton, SVP, Global Medicines Group, will present on Wednesday,
February 27, 2013.
|
What:
|
|
Teva Presentation at the 2013 RBC Capital Markets Global Healthcare
Conference
|
|
|
|
|
|
Who:
|
|
Jon Congleton, SVP, Global Medicines Group
|
|
|
|
|
|
When:
|
|
Wednesday, February 27 2013 at 1:30 PM (EST)
|
|
|
|
|
|
Where:
|
|
www.tevapharm.com
or
|
|
|
|
http://www.veracast.com/webcasts/rbc/healthcare2013/38211345.cfm
|
|
|
|
|
|
How:
|
|
Live over the Internet – log on to the Web at the address above and
register for the
|
|
|
|
event (approximately 10 minutes before). An archive of the webcast
will be available
|
|
|
|
on Teva’s website.
|
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic
drugs as well as innovative and specialty pharmaceuticals and active
pharmaceutical ingredients. Headquartered in Israel, Teva is the world's
leading generic drug maker, with a global product portfolio of more than
1,000 molecules and a direct presence in about 60 countries. Teva's
branded businesses focus on CNS, oncology, pain, respiratory and women's
health therapeutic areas as well as biologics. Teva currently employs
approximately 46,000 people around the world and reached $20.3 billion
in net revenues in 2012.
Source: Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
IR:
Kevin C.
Mannix
United States
215-591-8912
or
Kristen
Frank
United States
215-591-8908
or
Tomer
Amitai
Israel
972 (3) 926-7656
or
PR:
Hadar
Vismunski-Weinberg
Israel
972 (3) 926-7687
or
Denise
Bradley
United States
215-591-8974